WWARN is a global collaboration working to ensure that anyone affected by malaria receives effective and safe drug treatment. WWARN will provide urgently needed, comprehensive, timely and quality-assured intelligence to track the emergence of malarial drug resistance. More about WWARN

Clinical responses of malaria patients treated with various drugs Find out more
Precise antimalarial drug concentrations and pharmacokinetic parameters for key target populationsFind out more
In vitro drug susceptibility results from malaria parasites collected from infected patientsFind out more
Molecular markers for drug resistance in malaria parasitesFind out more
Use this interactive tool to explore results from studies examining complementary aspects of antimalarial drug resistance: treatment outcomes and measures from clinical trials of drug efficacy; pharmacological profiles of antimalarial drugs across key target populations; in vitro assessment of drug susceptibility of parasite isolates; and molecular markers of parasite resistance. Find out more